|
Real-time Estimate
Cboe BZX
10:55:05 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 17.64 USD | -0.42% |
|
+1.00% | +41.33% |
| 09-28 | Zymeworks Completes Acquisition of Theravance Biopharma; Updates 2026 Guidance | MT |
| 09-28 | Mylan seeks to clear patent obstacle for generic Wegovy | FW |
| Market Cap | 20.35B 17.92B 16.98B 15.33B 28.89B 1,952B 29.27B 203B 78.19B 998B 76.43B 74.76B 3,198B | P/E 2026 * |
76.3x | P/E 2027 * | 43.6x |
|---|---|---|---|---|---|
| Enterprise Value | 32.3B 28.45B 26.95B 24.33B 45.86B 3,097B 46.45B 322B 124B 1,583B 121B 119B 5,077B | EV / Sales 2026 * |
2.18x | EV / Sales 2027 * | 2.06x |
| Free-Float |
91.44% | Yield 2026 * |
2.87% | Yield 2027 * | 2.95% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VTRS | Delayed | |
CBOE
| VTRS | Real-time | |
|
Tradegate
| VIA | Real-time | |
|
Boerse Muenchen
| VIA | Real-time | |
|
Xetra
| VIA | Delayed | |
|
Börse Stuttgart
| VIA | Delayed | |
|
Deutsche Boerse AG
| VIA | Delayed | |
|
Borsa Italiana
| 1VTRS | End-of-day quote | |
|
Mexican S.E.
| VTRS * | End-of-day quote | |
|
London S.E.
| 0A5V | Delayed | |
|
Wiener Boerse
| VTRS | End-of-day quote | |
|
Swiss Exchange
| VTRS | Delayed | |
|
Swiss Exchange
| VTRS | Delayed | |
|
CBOE
| 0A5V | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Viatris Inc.
| 1 day | -0.42% | ||
| 1 week | +1.00% | ||
| Current month | -0.71% | ||
| 1 month | +5.80% | ||
| 3 months | +8.75% | ||
| 6 months | +29.09% | ||
| Current year | +41.33% |
| 1 week | 17.37 |  | 18.43 |
| 1 month | 16.15 | | 18.43 |
| Current year | 12.19 | | 18.43 |
| 1 year | 9.69 | | 18.43 |
| 3 years | 6.85 | | 18.43 |
| 5 years | 6.85 | | 18.43 |
| 10 years | 6.85 | | 47.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Smith
CEO | Chief Executive Officer | 63 | 2023-03-31 |
Paul Campbell
DFI | Director of Finance/CFO | 59 | 2026-05-07 |
Philippe Martin
CTO | Chief Tech/Sci/R&D Officer | - | 2023-12-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Wyllie Cornwell
BRD | Director/Board Member | 78 | 2020-11-15 |
James Kilts
BRD | Director/Board Member | 78 | 2020-11-15 |
JoEllen Dillon
BRD | Director/Board Member | 62 | 2020-11-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/15/26 | Exercice | Chief Administrative Officer | 63,631 | 0.0054% | ||
| 6/30/26 | Free | Director | 2,756 | 0.0002% | ||
| 6/30/26 | Free | Director | 2,362 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.42% | +1.00% | +74.38% | +75.07% | 20.35B | |
| -0.32% | -3.21% | +38.59% | +112.51% | 1,031B | |
| -0.79% | -3.08% | +41.01% | +69.09% | 638B | |
| -0.43% | -2.15% | +6.15% | +74.99% | 462B | |
| -0.30% | -2.34% | +60.34% | +40.92% | 359B | |
| -0.21% | -4.38% | +23.10% | +40.09% | 335B | |
| -1.78% | -0.99% | +13.23% | +26.14% | 273B | |
| -1.82% | -3.06% | -3.35% | +9.77% | 253B | |
| -1.41% | +2.21% | +39.03% | +55.83% | 228B | |
| -0.79% | -1.40% | +32.79% | +99.19% | 185B | |
| Average | -0.83% | +0.02% | +32.53% | +60.36% | 378.42B | |
| Weighted average by Cap. | -0.73% | -0.33% | +31.03% | +70.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.79B 13.02B 12.34B 11.14B 21B 1,418B 21.27B 148B 56.81B 725B 55.53B 54.32B 2,324B | 15.04B 13.24B 12.55B 11.33B 21.35B 1,442B 21.62B 150B 57.77B 737B 56.46B 55.23B 2,363B |
| Net income | 142M 125M 118M 107M 201M 13.57B 204M 1.41B 544M 6.94B 531M 520M 22.24B | 298M 263M 249M 225M 424M 28.61B 429M 2.98B 1.15B 14.63B 1.12B 1.1B 46.89B |
| Net Debt | 11.95B 10.52B 9.97B 9B 16.97B 1,146B 17.19B 119B 45.91B 586B 44.88B 43.9B 1,878B | 10.68B 9.41B 8.91B 8.05B 15.17B 1,024B 15.36B 107B 41.04B 524B 40.12B 39.24B 1,679B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-01 | US$17.59 | -0.76% | 1,029,205 |
| 26-09-30 | US$17.72 | -2.21% | 11,806,880 |
| 26-09-29 | US$18.12 | -0.82% | 13,858,063 |
| 26-09-28 | US$18.27 | +2.47% | 12,377,188 |
| 26-09-25 | US$17.83 | +2.35% | 10,152,781 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VTRS Stock
Select your edition
All financial news and data tailored to specific country editions
